Opaleye Management Inc. sold $1.1M of Harrow (HROW)

Executed Jan 6, disclosed Jan 8, 2 days later.

Value, as filed

$1.1M

20,000 sh × $53.35

Executed

Jan 6

the trade date, as filed

Disclosed

Jan 8

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

OI Opaleye Management Inc. 10% owner profile →

Opaleye Management Inc. (10% owner) filed 36 Form 4 reports as a reporting entity in the trailing twelve months (22 purchases, 14 sales, 3 filed past the two-business-day deadline), most often in CDXS. Across 18 priced purchase filings, the average 21-session return was +19.2% from execution and +19.4% from disclosure (delay-adjusted; derived). The largest single filing was $7.8M of HROW (197,263 sh across 3 lots, as filed), executed Mar 3.

The name

HROW Harrow, Inc. HROW · Healthcare · 14 filings in 24 months ticker →

Healthcare · Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Opaleye Management Inc. in HROW

HROWSALE Harrow, Inc. $7.8M
197,263 sh across 3 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET HROWSALE Harrow, Inc. $271K
5,000 sh × $54.18
Exec Feb 27
Filed Mar 3 · 5:30 PM ET HROWSALE Harrow, Inc. $924K
30,204 sh across 2 lots
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET HROWSALE Harrow, Inc. $392K
15,000 sh across 2 lots
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET HROWSALE Harrow, Inc. $150K
5,000 sh × $30.01
Exec Mar 24 2025
Filed May 14 2025 · 5:30 PM ET † HROWSALE Harrow, Inc. $148K
5,000 sh × $29.64
Exec Mar 18 2025
Filed May 14 2025 · 5:30 PM ET † HROWSALE Harrow, Inc. $148K
5,000 sh × $29.64
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET HROWSALE Harrow, Inc. $150K
5,000 sh × $30.01
Exec Mar 18 2025
Filed Mar 26 2025 · 5:30 PM ET †